Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K L Davis

Showing results (171-180 of 400) with videos related to

Pageof 40
Sort By:
Journal of the American Geriatrics Society|June 1, 1993
Functional decline in Alzheimer's disease: a longitudinal studyC R Green, R C Mohs, J Schmeidler, et al.
Endocrinology and Metabolism Clinics of North America|March 1, 1988
Endocrine changes in Alzheimer's diseaseM Davidson, L Bastiaens, B M Davis, et al.
Biological Psychiatry|June 15, 1994
Clozapine treatment and its effect on neuroendocrine responses induced by the serotonin agonist, m-chlorophenylpiperazineR S Kahn, M Davidson, L J Siever, et al.
Biological Psychiatry|October 6, 1999
Cognitive and functional changes with aging in schizophreniaJ I Friedman, P D Harvey, E Kemether, et al.
Blood|May 11, 1999
Regulated expression and functional role of the transcription factor CHOP (GADD153) in erythroid growth and differentiationM Coutts, K Cui, K L Davis, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 1998
Human erythropoietin dimers with markedly enhanced in vivo activityA J Sytkowski, E D Lunn, K L Davis, et al.
Experimental Hematology|November 1, 1993
Antipeptide antibodies as probes of the recombinant and endogenous murine erythropoietin receptorsS C Bailey, L Feldman, R R Romanowski, et al.
Glia|July 25, 2014
Myelination, oligodendrocytes, and serious mental illnessV Haroutunian, P Katsel, P Roussos, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1991
The cytochrome P450 metabolic pathway of arachidonic acid in the corneaM L Schwartzman, K L Davis, M Nishimura, et al.
Lancet (London, England)|January 20, 1990
Neurofibrillary tangles, Alzheimer's disease and Lewy bodiesL M Bierer, D P Perl, V Haroutunian, et al.
Pageof 40

Showing results (171-180 of 400) with videos related to

Sort By:
Pageof 40
Journal of the American Geriatrics Society|June 1, 1993
Functional decline in Alzheimer's disease: a longitudinal studyC R Green, R C Mohs, J Schmeidler, et al.
Endocrinology and Metabolism Clinics of North America|March 1, 1988
Endocrine changes in Alzheimer's diseaseM Davidson, L Bastiaens, B M Davis, et al.
Biological Psychiatry|June 15, 1994
Clozapine treatment and its effect on neuroendocrine responses induced by the serotonin agonist, m-chlorophenylpiperazineR S Kahn, M Davidson, L J Siever, et al.
Biological Psychiatry|October 6, 1999
Cognitive and functional changes with aging in schizophreniaJ I Friedman, P D Harvey, E Kemether, et al.
Blood|May 11, 1999
Regulated expression and functional role of the transcription factor CHOP (GADD153) in erythroid growth and differentiationM Coutts, K Cui, K L Davis, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 1998
Human erythropoietin dimers with markedly enhanced in vivo activityA J Sytkowski, E D Lunn, K L Davis, et al.
Experimental Hematology|November 1, 1993
Antipeptide antibodies as probes of the recombinant and endogenous murine erythropoietin receptorsS C Bailey, L Feldman, R R Romanowski, et al.
Glia|July 25, 2014
Myelination, oligodendrocytes, and serious mental illnessV Haroutunian, P Katsel, P Roussos, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1991
The cytochrome P450 metabolic pathway of arachidonic acid in the corneaM L Schwartzman, K L Davis, M Nishimura, et al.
Lancet (London, England)|January 20, 1990
Neurofibrillary tangles, Alzheimer's disease and Lewy bodiesL M Bierer, D P Perl, V Haroutunian, et al.
Pageof 40